Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas (2021)
Source: Molecules. Unidade: ICB
Subjects: FARMACOLOGIA, APOPTOSE, PRODUTOS NATURAIS, PEPTÍDEOS, AMINOÁCIDOS, CÉLULAS CULTIVADAS DE TUMOR, MELANOMA, MOLÉCULA, BACTÉRIAS AERÓBICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Amanda Soares et al. Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas. Molecules, v. 26, n. 23, p. 1-15, 2021Tradução . . Disponível em: https://doi.org/10.3390/molecules26237362. Acesso em: 01 maio 2024.APA
Hirata, A. S., Teixeira, P. R., Machado Neto, J. A., Jimenez, P. C., Clair, J. J. L., Fenical, W., & Lotufo, L. V. C. (2021). Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas. Molecules, 26( 23), 1-15. doi:10.3390/molecules26237362NLM
Hirata AS, Teixeira PR, Machado Neto JA, Jimenez PC, Clair JJL, Fenical W, Lotufo LVC. Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas [Internet]. Molecules. 2021 ; 26( 23): 1-15.[citado 2024 maio 01 ] Available from: https://doi.org/10.3390/molecules26237362Vancouver
Hirata AS, Teixeira PR, Machado Neto JA, Jimenez PC, Clair JJL, Fenical W, Lotufo LVC. Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas [Internet]. Molecules. 2021 ; 26( 23): 1-15.[citado 2024 maio 01 ] Available from: https://doi.org/10.3390/molecules26237362